Most PI managing partners intuitively suspect the answer to this question but cannot prove it. They either feel like they are spending too much and not seeing the cases to justify it, or they feel like they are leaving growth on the table by not spending more aggressively.
Both problems are real. Both are solvable. And both require the same thing: a financial model that connects your marketing spend to your case output and expected revenue — so that over- and under-investment are visible, not just felt.
What Over-Investment Actually Looks Like
Over-investment in lead generation is not simply “spending too much.” It is spending at a cost per case that exceeds your break-even acquisition economics — meaning each additional case you sign is consuming firm capital rather than generating it.
The signals are specific:
- Cost per signed case is above your break-even threshold. If your average contingency fee is $7,500 and your break-even acquisition cost (after operating costs and target margin) is $4,800, a blended cost per case of $6,200 means every case is costing you more than the financial model justifies.
- Marketing spend is growing faster than signed case volume. If you increased marketing spend by 20% this year and signed cases grew by 8%, the incremental return on that investment is well below your target. The additional spend is not producing proportional outcomes.
- Underperforming vendors are being retained on volume metrics. A vendor delivering 80 leads per month at $250 each looks active. If those leads convert to signed cases at 12% and the cases cluster in low-severity categories, the vendor may be consuming $20,000 per month to produce cases at $9,500 cost each — nearly double your break-even.
- Intake team capacity is maxed but signed cases are flat. A saturated intake team working excessive lead volume at low conversion rates is a classic over-investment signal. You are paying for more leads than your intake operation can productively convert.
The uncomfortable truth about over-investment: it often looks like growth because the activity numbers are high. Lead volume is strong. The intake team is busy. Vendor invoices are paid. What is not visible without attribution data is the margin destruction happening below the surface.
What Under-Investment Actually Looks Like
Under-investment is a different problem — and for growing PI firms, often a more expensive one. It means you have capacity to sign and work more cases profitably, but insufficient marketing investment to generate the lead volume required to fill that capacity.
The signals:
- Cost per signed case is well below break-even, but case volume is flat or declining. If your best vendor is producing cases at $2,800 against a break-even of $4,800, you have $2,000 per case of headroom to invest more aggressively in that channel. Staying at the same budget level means leaving profitable case volume unrealized.
- Intake conversion rate is high but intake team has spare capacity. An intake team converting 42% of qualified leads with 20–30% idle time suggests lead volume is constraining performance, not intake effectiveness. The constraint is upstream — in lead generation investment.
- Revenue targets are missed while marketing budget is consistently underspent. If your firm budgets $180,000 per month and consistently runs at $155,000 without hitting case targets, the under-spend is the contributing factor — not a success story.
- High-performing vendors have artificially capped budgets. This is the most common form of under-investment. A vendor performing at $3,100 cost per case against a $4,800 break-even gets maintained at the same $40,000 monthly allocation for 18 months because nobody ran the math on what increasing to $65,000 would return.
| Signal | Over-Investing | Under-Investing | |
|---|---|---|---|
| CPC vs. Break-Even | Exceeds by 10%+ | 30%+ below, volume flat | |
| Spend Growth vs. Cases | Spend up 20%, cases up 8% | Spend up 5%, revenue up 18% | |
| Intake Status | Maxed but cases flat | High conversion, spare capacity | |
| Vendor Budgets | Underperformers retained | Top performers capped artificially |
The Diagnostic Framework: Three Ratios to Calculate
Whether the problem is over- or under-investment, the same three ratios reveal it.
Ratio 1: Marketing Spend as a Percentage of Expected Case Revenue
Calculate: (Total monthly marketing spend + Intake labor cost) ÷ Expected monthly case revenue
Expected case revenue = Signed cases this month × Average expected contingency fee per case
Benchmark: For mid-size PI firms, a healthy range is 15–28% of expected case revenue. Below 15% may indicate under-investment if you have capacity to sign more cases. Above 28% signals over-investment or margin compression.
Ratio 2: Blended Cost Per Case vs. Break-Even Cost Per Case
Calculate your firm's break-even cost per case (see the separate article on this calculation). Compare your actual blended cost per case to that threshold.
Over-investment signal: Actual exceeds break-even by more than 10%.
Under-investment signal: Actual is more than 30% below break-even and case volume is not meeting targets.
Ratio 3: Revenue Growth Rate vs. Marketing Spend Growth Rate
Compare the year-over-year growth rate of your expected case revenue to the growth rate of your marketing spend. If marketing spend grew 25% and expected case revenue grew 12%, incremental returns are declining — a classic over-investment indicator. If marketing spend grew 5% and expected case revenue grew 18%, you have capacity to invest more aggressively in the channels producing that growth.
Spend as % of Case Revenue
15-28%
Below 15% = under-investing. Above 28% = over-investing.
CPC vs. Break-Even
Within 10%
Over 10% above = over-investing. 30%+ below = room to grow.
Revenue Growth vs. Spend Growth
Aligned
Divergence signals misallocation
What to Do Once You Know Which Problem You Have
If You Are Over-Investing
The first step is vendor-level cost analysis. Calculate cost per signed case for each vendor independently. Sort them from lowest to highest. The vendors above your break-even threshold are consuming excess capital. Renegotiate pricing, set performance improvement timelines, and exit vendors who cannot hit sustainable cost per case within 90 days.
Do not simply cut total spend. Reallocate — move capital from above- break-even sources to below-break-even sources. The goal is to reduce blended cost per case while maintaining or increasing signed case volume.
If You Are Under-Investing
Identify your highest-performing vendors — those operating well below break-even with consistent case quality. These are the channels where additional investment produces predictable returns. Model the expected output of a budget increase using your historical cost per case and conversion data, then make the case to partners with projected ROI, not anecdote.
Also evaluate intake capacity. If you increase lead volume by 30%, can your intake team handle it? An under-invested marketing operation with an intake team at capacity will not produce proportional case growth from additional spend.
If Over-Investing
- Calculate cost per case for each vendor independently
- Identify vendors above break-even threshold
- Reallocate — don't just cut total spend
- Set 90-day performance improvement timelines
- Exit vendors who can't hit sustainable CPC
If Under-Investing
- Identify vendors operating well below break-even
- Model expected output of budget increases
- Evaluate intake team capacity for higher volume
- Present projected ROI to partners with data
- Scale high-performers with artificially capped budgets
Why Most PI Firms Cannot Run This Diagnostic Today
The diagnostic above requires vendor-level cost per case data, which requires source tagging from lead to signed case. Most PI firms tracking marketing ROI manually in spreadsheets do not have this linkage — which means they cannot calculate vendor-level cost per case, compare it to break-even, or identify which sources are consuming excess capital.
The firms that solve this problem first — that build the attribution infrastructure to connect lead source to case outcome — gain a compounding financial advantage. Every month of better reallocation compounds into a lower blended cost per case and higher return per marketing dollar. Firms that are 15–20% more efficient in their marketing ROI than competitors are not necessarily spending less. They are spending smarter.
RevenueScale's vendor-level attribution dashboard gives PI managing partners the data required to make over/under-investment calls with confidence — source-by-source, updated in real time.